Valuation: UCB

Market Cap 45.25B 51.77B 41.85B 38.4B 72.68B 4,988B 73.94B 499B 196B 2,436B 194B 190B 8,410B P/E 2026 *
25.5x
P/E 2027 * 20.2x
Enterprise Value 44.98B 51.46B 41.6B 38.17B 72.24B 4,958B 73.49B 496B 195B 2,421B 193B 189B 8,359B EV / Sales 2026 *
5.27x
EV / Sales 2027 * 4.46x
Free-Float
61.59%
Yield 2026 *
0.62%
Yield 2027 * 0.63%
1 day+0.85%
1 week-4.92%
Current month-9.27%
1 month-4.92%
3 months-8.12%
6 months-10.50%
Current year-0.38%
1 week 230.7
Extreme 230.7
238.7
1 month 230.7
Extreme 230.7
268.3
Current year 223
Extreme 223
289.5
1 year 169.35
Extreme 169.35
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 59 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Buy

Director

500 0.0003%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+0.85%-4.92%+40.11%+199.67% 51.77B
+2.18%+1.65%+23.91%-5.51% 69.07B
+0.94%+39.60%+39.60%+39.60% 43.63B
+1.12%+0.35%-50.35%-52.35% 40.89B
+5.92%+5.03%+62.63%-25.10% 30.84B
-7.51%-17.52%+96.97%-47.96% 25.06B
+1.36%-1.58%+68.50%+88.88% 23.3B
-5.36%-0.28%+0.39%+183.97% 20.92B
+2.15%-2.72%+64.59%+129.01% 16.71B
-2.86%-10.95%+70.49%+340.72% 15.74B
Average -0.09%-2.50%+41.68%+85.09% 33.79B
Weighted average by Cap. +0.57%-1.80%+34.18%+62.16%

Financials

2026 *2027 *
Net sales 8.54B 9.77B 7.9B 7.25B 13.71B 941B 13.95B 94.18B 37B 460B 36.69B 35.88B 1,587B 9.64B 11.02B 8.91B 8.18B 15.48B 1,062B 15.75B 106B 41.75B 519B 41.4B 40.49B 1,791B
Net income 1.77B 2.02B 1.63B 1.5B 2.84B 195B 2.88B 19.47B 7.65B 95.03B 7.58B 7.42B 328B 2.27B 2.6B 2.1B 1.93B 3.65B 251B 3.72B 25.08B 9.85B 122B 9.77B 9.55B 423B
Net Debt -271M -310M -251M -230M -436M -29.91B -443M -2.99B -1.18B -14.6B -1.17B -1.14B -50.42B -2.31B -2.65B -2.14B -1.96B -3.72B -255B -3.78B -25.51B -10.02B -125B -9.94B -9.72B -430B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,765
Date Price Change Volume
26-07-17 237.00 -0.29% 1,838
26-07-16 €237.70 +0.85% 128,758
26-07-15 €235.70 +1.38% 167,608
26-07-14 €232.50 -1.32% 152,960
26-07-13 €235.60 -0.63% 192,311
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
237.70EUR
Average target price
287.95EUR
Spread / Average Target
+21.14%

Quarterly revenue - Rate of surprise